Daniel Ortega Email

Director, Chemistry,Manufacturing, and Controls . PLUS THERAPEUTICS

Current Roles

Employees:
24
Revenue:
$2.4M
About
PLUS THERAPEUTICS (Nasdaq: PSTV) is a U.S. clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for adults and children with rare and difficult-to-treat cancers. Our lead drug candidate, Rhenium-186 Nanoliposome, is being evaluated in the NIH-supported multi-center ReSPECT clinical trials for patients with recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancer.
PLUS THERAPEUTICS Address
4200 Marathon Blvd
Austin, TX
United States
PLUS THERAPEUTICS Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.